Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Seneca Biopharma announced the completion of its new cell manufacturing facility in Suzhou, China.
read more
Samsung Biologics entered into a strategic partnership with PharmAbcine for the development and manufacturing of PMC-402 pipeline.
read more
Wednesday, April 15, 2020
HALIX has joined a consortium of partners to provide GMP manufacturing services supporting the large scale production of a COVID-19 vaccine being developed by the University’s Jenner Institute.
read more
MilliporeSigma and The Jenner Institute announced The Jenner Institute has laid the foundation for large-scale production of its Covid-19 vaccine candidate, ChAdOx1 nCoV-19.
read more
The FDA plays a critical role in protecting the United States from threats such as emerging infectious diseases, including the COVID-19 pandemic.
read more
Aceto has announced its acquisition of Syntor Fine Chemicals.
read more
The FDA announced a further expansion of COVID-19 testing options through the recognition that spun synthetic swabs could be used to test patients by collecting a sample from the front of the nose.
read more
Wednesday, April 22, 2020
Keystone Folding Box has incorporated new die cutting and gluing equipment into its production facility.
read more
Shanghai Henlius Biotech announced the company's drug substance line and drug product line for trastuzumab biosimilar have passed the EU GMP on-site inspection.
read more
AGC Biologics is partnering with AdaptVac to develop and produce a COVID-19 vaccine.
read more
AMRI announced the company’s manufacturing facility in Rensselaer, NY has been designated “Industry Leader” as part of its re-certification under the SafeBridge® program for "Potent Compound Safety Certification."
read more
Clearside Biomedical announced an update to the XIPERE NDA resubmission timeline and to its commercialization and development partnership with Bausch Health and Bausch + Lomb, its global eye health business.
read more
Moderna and Lonza announced a 10-year strategic collaboration agreement to enable larger scale manufacture of Moderna’s mRNA vaccine against the novel coronavirus.
read more
Ajinomoto Bio-Pharma Services has entered into a manufacturing services agreement with CytoDyn for the supply of the investigational new drug, leronlimab.
read more
Aravive and WuXi Biologics announced a strategic collaboration agreement granting Aravive the right to use the proprietary WuXiBody™ platform to develop high-affinity bispecific antibodies for a target implicated in cancer and fibrosis.
read more